Helmerich & Payne (NYSE: HP ) is expected to report Q1 earnings around Jan. 31. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Helmerich & Payne's revenues will grow 12.5% and EPS will wane 0.0%.
The average estimate for revenue is $823.8 million. On the bottom line, the average EPS estimate is $1.29.
Revenue details
Last quarter, Helmerich & Payne booked revenue of $829.4 million. GAAP reported sales were 18% higher than the prior-year quarter's $700.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $1.36. GAAP EPS of $1.46 for Q4 were 32% higher than the prior-year quarter's $1.11 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 46.1%, 270 basis points better than the prior-year quarter. Operating margin was 30.3%, 260 basis points better than the prior-year quarter. Net margin was 18.9%, 160 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $3.34 billion. The average EPS estimate is $4.99.
Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 1,011 members out of 1,086 rating the stock outperform, and 75 members rating it underperform. Among 221 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 209 give Helmerich & Payne a green thumbs-up, and 12 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Helmerich & Payne is outperform, with an average price target of $56.10.
Is Helmerich & Payne the right energy stock for you? Read about a handful of timely, profit-producing plays on expensive crude in "3 Stocks for $100 Oil." Click here for instant access to this free report.
- Add Helmerich & Payne to My Watchlist.
No comments:
Post a Comment